Tourmaline Bio (TRML) Institutional Ownership

$15.50
-0.18 (-1.15%)
(As of 04/29/2024 ET)

Institutional Ownership Changes (13F Filings) for Tourmaline Bio (NASDAQ:TRML)

Current
Institutional Ownership
Percentage
91.89%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$98.81M
Number of
Institutional Sellers
(last 12 months)
0
Get TRML Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tourmaline Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TRML Institutional Buying and Selling by Quarter

Tourmaline Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/29/2024China Universal Asset Management Co. Ltd.4,939$113K0.0%+109.5%0.019%
4/19/2024 Denali Advisors LLC5,600$128K0.0%N/A0.022%
2/15/2024Great Point Partners LLC672,885$17.62M3.0%N/A3.308%
2/14/2024Braidwell LP906,820$23.74M0.9%N/A4.458%
2/14/2024Avoro Capital Advisors LLC868,407$22.74M0.3%N/A4.269%
2/14/2024RTW Investments LP398,850$10.44M0.2%N/A1.961%
2/13/2024Affinity Asset Advisors LLC68,081$1.78M0.3%N/A0.335%
2/7/2024Jump Financial LLC14,500$380K0.0%N/A0.071%
2/7/2024 Vivo Capital LLC591,882$15.50M1.3%N/A2.910%
1/30/2024 BML Capital Management LLC245,500$6.43M4.9%N/A1.207%
(Data available from 1/1/2016 forward)

TRML Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TRML shares?

During the previous two years, 10 institutional investors and hedge funds held shares of Tourmaline Bio. The most heavily invested institutionals were Braidwell LP ($23.74M), Avoro Capital Advisors LLC ($22.74M), Great Point Partners LLC ($17.62M), Vivo Capital LLC ($15.50M), RTW Investments LP ($10.44M), BML Capital Management LLC ($6.43M), and Affinity Asset Advisors LLC ($1.78M).Learn more on TRML's institutional investors.

What percentage of Tourmaline Bio stock is owned by institutional investors?

91.89% of Tourmaline Bio stock is owned by institutional investors. Learn more on TRML's institutional investor holdings.

Which institutional investors have been buying Tourmaline Bio stock?

Of the 10 institutional investors that purchased Tourmaline Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($906.82K), Avoro Capital Advisors LLC ($868.41K), Great Point Partners LLC ($672.89K), Vivo Capital LLC ($591.88K), RTW Investments LP ($398.85K), BML Capital Management LLC ($245.50K), and Affinity Asset Advisors LLC ($68.08K).

How much institutional buying is happening at Tourmaline Bio?

Institutional investors have bought a total of 3,775,107 shares in the last 24 months. This purchase volume represents approximately $98.81M in transactions.


This page (NASDAQ:TRML) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners